Diversified Healthcare Trust to Announce Q1 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy DHC?
Source: seekingalpha
- Earnings Announcement Schedule: Diversified Healthcare Trust (DHC) is set to release its Q1 earnings on May 4th after market close, with consensus EPS estimate at -$0.16 and revenue estimate at $380.18 million, indicating market caution regarding the company's financial performance.
- Historical Performance: Over the past year, DHC has beaten EPS estimates 100% of the time, while only achieving a 50% beat rate on revenue, suggesting stable profitability but challenges in revenue growth.
- Future Outlook: DHC has outlined an adjusted EBITDA target of $290 million to $305 million for 2026, driven by growth in its SHOP (Senior Housing Operating Portfolio) segment and progress in deleveraging, which will enhance the company's financial health.
- Market Focus: Investors will closely monitor the upcoming earnings report to assess DHC's performance in the current economic environment and its future growth potential, particularly amid the challenges and opportunities facing the healthcare sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DHC
Wall Street analysts forecast DHC stock price to fall
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 7.540
Low
3.00
Averages
3.75
High
4.50
Current: 7.540
Low
3.00
Averages
3.75
High
4.50
About DHC
Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Diversified Healthcare Trust to Announce Q1 Earnings
- Earnings Announcement Schedule: Diversified Healthcare Trust (DHC) is set to release its Q1 earnings on May 4th after market close, with consensus EPS estimate at -$0.16 and revenue estimate at $380.18 million, indicating market caution regarding the company's financial performance.
- Historical Performance: Over the past year, DHC has beaten EPS estimates 100% of the time, while only achieving a 50% beat rate on revenue, suggesting stable profitability but challenges in revenue growth.
- Future Outlook: DHC has outlined an adjusted EBITDA target of $290 million to $305 million for 2026, driven by growth in its SHOP (Senior Housing Operating Portfolio) segment and progress in deleveraging, which will enhance the company's financial health.
- Market Focus: Investors will closely monitor the upcoming earnings report to assess DHC's performance in the current economic environment and its future growth potential, particularly amid the challenges and opportunities facing the healthcare sector.
See More
Diversified Healthcare Trust Declares Quarterly Dividend
- Quarterly Dividend Announcement: Diversified Healthcare Trust (DHC) declares a quarterly dividend of $0.01 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain cash flow stability despite limited earnings growth.
- Yield Information: The forward yield of this dividend stands at 0.57%, reflecting the company's attractiveness in the current market environment, although the overall low yield may impact long-term investor confidence.
- Shareholder Arrangement: The dividend is payable on May 14, with a record date of April 21 and an ex-dividend date also on April 21, ensuring shareholders receive timely returns and enhancing trust in the company.
- Future Financial Targets: DHC outlines an adjusted EBITDA target of $290 million to $305 million for 2026, indicating growth potential in the SHOP (Senior Housing Operating Portfolio) segment and progress in deleveraging, which may lay the groundwork for future financial stability.
See More
Diversified Healthcare Trust to Release Q1 2026 Financial Results
- Earnings Release Schedule: Diversified Healthcare Trust (DHC) plans to issue its Q1 2026 financial results after Nasdaq closes on May 4, 2026, demonstrating the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on May 5, 2026, at 10:00 a.m. Eastern Time, led by CEO Christopher Bilotto and other executives, which is expected to attract investor interest and provide in-depth analysis of financial performance.
- Investor Participation: Participants can join the call by dialing (877) 329-4297 or (412) 317-5435 for international calls, reflecting the company's efforts to maintain global investor engagement.
- Webcast and Replay Availability: The conference will be available via live audio webcast on the company's website, with a replay accessible until May 12, 2026, enhancing information accessibility and transparency.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Stake Liquidation: Flat Footed LLC fully liquidated its 314,076-share stake in Matson during Q4 2026, resulting in a $30.96 million decrease in the position's quarter-end value, highlighting the impact of market fluctuations on its investment portfolio.
- Market Performance: As of February 17, 2026, Matson's shares were priced at $165.05, reflecting a 12.1% increase over the past year, outperforming the S&P 500 by 2.27 percentage points, indicating its relative strength in the shipping industry.
- Financial Overview: Matson's latest financial metrics reveal a TTM revenue of $3.34 billion and a net income of $444.8 million, with a dividend yield of 0.91%, suggesting a solid revenue stream and profitability.
- Industry Outlook: While global freight markets stabilize, Matson must focus on cargo demand in its domestic trade lanes and customers' willingness to pay for expedited shipping services to sustain profitability and competitive positioning.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Position Liquidation: Flat Footed LLC sold its entire stake of 314,076 shares in Matson during Q4, resulting in an estimated trade size of $30.96 million, which led to a 3.4% decrease in its reported AUM.
- Market Dynamics Impact: This transaction reflects not only the liquidation of Flat Footed LLC's holdings but also the impact of Matson's stock price fluctuations, resulting in a quarter-end position value of zero, down from 3.8% of the fund's AUM in the previous quarter.
- Industry Competitiveness: Matson, a leading provider of ocean transportation and logistics services, focuses on domestic U.S. trade lanes, particularly in Hawaii, Alaska, and Guam, benefiting from the protection of the Jones Act, which limits foreign competition.
- Future Outlook: While Matson benefited from strong trans-Pacific demand and premium pricing during the pandemic, its profitability will depend on continued cargo demand in domestic trade lanes and customers' willingness to pay for expedited shipping as global freight markets stabilize.
See More
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
- Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
- Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
- Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
- Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
See More
Diversified Healthcare Trust to Announce Q1 Earnings
- Earnings Announcement Schedule: Diversified Healthcare Trust (DHC) is set to release its Q1 earnings on May 4th after market close, with consensus EPS estimate at -$0.16 and revenue estimate at $380.18 million, indicating market caution regarding the company's financial performance.
- Historical Performance: Over the past year, DHC has beaten EPS estimates 100% of the time, while only achieving a 50% beat rate on revenue, suggesting stable profitability but challenges in revenue growth.
- Future Outlook: DHC has outlined an adjusted EBITDA target of $290 million to $305 million for 2026, driven by growth in its SHOP (Senior Housing Operating Portfolio) segment and progress in deleveraging, which will enhance the company's financial health.
- Market Focus: Investors will closely monitor the upcoming earnings report to assess DHC's performance in the current economic environment and its future growth potential, particularly amid the challenges and opportunities facing the healthcare sector.
See More
Diversified Healthcare Trust Declares Quarterly Dividend
- Quarterly Dividend Announcement: Diversified Healthcare Trust (DHC) declares a quarterly dividend of $0.01 per share, consistent with previous distributions, indicating the company's ongoing ability to maintain cash flow stability despite limited earnings growth.
- Yield Information: The forward yield of this dividend stands at 0.57%, reflecting the company's attractiveness in the current market environment, although the overall low yield may impact long-term investor confidence.
- Shareholder Arrangement: The dividend is payable on May 14, with a record date of April 21 and an ex-dividend date also on April 21, ensuring shareholders receive timely returns and enhancing trust in the company.
- Future Financial Targets: DHC outlines an adjusted EBITDA target of $290 million to $305 million for 2026, indicating growth potential in the SHOP (Senior Housing Operating Portfolio) segment and progress in deleveraging, which may lay the groundwork for future financial stability.
See More
Diversified Healthcare Trust to Release Q1 2026 Financial Results
- Earnings Release Schedule: Diversified Healthcare Trust (DHC) plans to issue its Q1 2026 financial results after Nasdaq closes on May 4, 2026, demonstrating the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on May 5, 2026, at 10:00 a.m. Eastern Time, led by CEO Christopher Bilotto and other executives, which is expected to attract investor interest and provide in-depth analysis of financial performance.
- Investor Participation: Participants can join the call by dialing (877) 329-4297 or (412) 317-5435 for international calls, reflecting the company's efforts to maintain global investor engagement.
- Webcast and Replay Availability: The conference will be available via live audio webcast on the company's website, with a replay accessible until May 12, 2026, enhancing information accessibility and transparency.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Stake Liquidation: Flat Footed LLC fully liquidated its 314,076-share stake in Matson during Q4 2026, resulting in a $30.96 million decrease in the position's quarter-end value, highlighting the impact of market fluctuations on its investment portfolio.
- Market Performance: As of February 17, 2026, Matson's shares were priced at $165.05, reflecting a 12.1% increase over the past year, outperforming the S&P 500 by 2.27 percentage points, indicating its relative strength in the shipping industry.
- Financial Overview: Matson's latest financial metrics reveal a TTM revenue of $3.34 billion and a net income of $444.8 million, with a dividend yield of 0.91%, suggesting a solid revenue stream and profitability.
- Industry Outlook: While global freight markets stabilize, Matson must focus on cargo demand in its domestic trade lanes and customers' willingness to pay for expedited shipping services to sustain profitability and competitive positioning.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Position Liquidation: Flat Footed LLC sold its entire stake of 314,076 shares in Matson during Q4, resulting in an estimated trade size of $30.96 million, which led to a 3.4% decrease in its reported AUM.
- Market Dynamics Impact: This transaction reflects not only the liquidation of Flat Footed LLC's holdings but also the impact of Matson's stock price fluctuations, resulting in a quarter-end position value of zero, down from 3.8% of the fund's AUM in the previous quarter.
- Industry Competitiveness: Matson, a leading provider of ocean transportation and logistics services, focuses on domestic U.S. trade lanes, particularly in Hawaii, Alaska, and Guam, benefiting from the protection of the Jones Act, which limits foreign competition.
- Future Outlook: While Matson benefited from strong trans-Pacific demand and premium pricing during the pandemic, its profitability will depend on continued cargo demand in domestic trade lanes and customers' willingness to pay for expedited shipping as global freight markets stabilize.
See More
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
- Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
- Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
- Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
- Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
See More
